Adaptive Biotechnologies Corporation
ADPT
$19.66
-$0.06-0.30%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -79.57M | -121.31M | -141.92M | -159.57M | -195.32M |
| Total Depreciation and Amortization | 18.09M | 18.27M | 18.77M | 19.26M | 20.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.22M | 53.99M | 61.09M | 62.56M | 89.49M |
| Change in Net Operating Assets | -52.26M | -31.42M | -23.29M | -17.45M | -24.02M |
| Cash from Operations | -60.53M | -80.47M | -85.34M | -95.21M | -109.65M |
| Capital Expenditure | -2.40M | -2.34M | -3.41M | -3.66M | -4.88M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.72M | 58.66M | 62.27M | 81.46M | 63.76M |
| Cash from Investing | 68.32M | 56.33M | 58.86M | 77.79M | 58.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.87M | 7.23M | 5.65M | 241.00K | 201.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.87M | 7.23M | 5.65M | 241.00K | 201.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.66M | -16.92M | -20.84M | -17.18M | -50.57M |